Resultados de la búsqueda 361-370 of 17439 for monoclonal antibody

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  4. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  6. Hematología - Ensayos clínicos

    ... monoclonal antibody, and compare them with clinical outcomes. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions.

  7. Hematología - Ensayos clínicos

    ... monoclonal antibody, and compare them with clinical outcomes. A Study to ... The purpose of this study is to evaluate the immune and hematopoietic compartments in ...

  8. Oncología (médica) - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...